RNF43 and colorectal adenocarcinoma: Using LURE, Haan et al. used driver BRAF missense mutations, which activate the MAPK/RTK pathway, to build a classifier and found samples with RNF43 truncating mutations to have higher classifier scores in TCGA colorectal adenocarcinoma patients [35].